alpha-Galactosidase A (alpha-D-galactoside galactohydrolase, EC 3.2.1.
22; alpha GalA) is a lysosomal enzyme that hydrolyses the alpha-D-gala
ctosyl residues from glycosphingolipids. Fabry disease, an inherited X
-linked recessive human metabolic disorder, results from a mutation in
the alpha GalA gene at Xq22. As a prerequisite for generating a mouse
model of Fabry disease by gene targeting, we have isolated and charac
terized the mouse alpha GalA gene and cDNA. A cloned mouse alpha GalA
cDNA encoded a putative precursor protein of 419 amino acids (aa), inc
luding a 31-aa signal peptide (SP), The deduced aa sequence showed hig
h homology (79%) with the human alpha GalA protein. Nucleotide sequenc
e analysis of genomic clones revealed that the overall structure and o
rganization of the gene was very similar to that of human alpha GalA.
All exon-intron splice junctions conformed to the GT/AG consensus sequ
ence. Comparison of genomic and cDNA sequences revealed the ocurrence
of two putative polyadenylation signals whose alternative use results
in the two mouse alpha GalA transcripts of 1.4 and 3.6 kb. The 5'-flan
king region of mouse alpha GalA had no typical TATA box. Several putat
ive promoter-associated elements including Sp1, AP1 and a potential cA
MP-responsive element (CRE) were identified. Northern blot analysis re
vealed the widespread tissue distribution of mouse alpha GalA transcri
pts. Lower expression levels, however, were observed in some tissues,
implying tissue-specific differences in alpha GalA promoter function.